HEStaff exchange2025–2029

STOP-MATING · Accelerating the development of mating disruptors for disease-transmitting mosquito control

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2025-03-01 → 2029-02-28
EU contribution
€257,600
Participants
8
Scheme
HORIZON-TMA-MSCA-SE

Lines connect the coordinator with its partners.

Project objective

STOP-MATING aims at building a research and innovation network to advance towards developing novel tools to target the mating behaviour of disease-transmitting mosquitoes for vector control. Challenges related to climate change and insecticide resistance are putting human populations at risk of mosquito-borne diseases. Novel strategies are required to tackle this public health challenge. In STOP-MATING we propose to use the mating systems of disease-transmitting mosquitoes as novel vector control targets. Although disrupting mosquito mating would have a clear impact on mosquito vector numbers, this mechanism is underexploited from a public health perspective. In STOP-MATING we bring together experts from academic and industrial partners with interdisciplinary expertise on bioinformatics, molecular neuroscience, genetic control, behaviour, biophysics, vector ecology and vector control to explore novel vector control approaches. Our objectives are to 1) identify molecular targets for mosquito mating disruption, 2) mutate those targets, 3) analyse associated behavioural effects and 4) explore their potential application into developing mating disruptors and gene drive systems for vector control. We also aim at exploiting the mating behaviour of mosquitoes to develop traps that mimic the environmental stimuli that they respond to during courtship behaviour. STOP-MATING approach is to merge knowledge from laboratory and field researchers to deliver real-world solutions, and to tackle different mosquito species of increasing public health relevance in Europe. Our innovative approaches have the potential to make great impact to reduce the health burden of mosquito-borne diseases.

Original text from CORDIS.

Participants

  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridCoordinatorSpain
  • BIOGENTS AG · RegensburgGermany
  • CARL VON OSSIETZKY UNIVERSITAET OLDENBURG · OldenburgGermany
  • IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE · LondonUnited Kingdom
  • Institut Pasteur de Bangui · BanguiCentral African Republic
  • Institut Pasteur de Madagascar · AntananarivoMadagascar
  • SEQUENTIA BIOTECH SL · BarcelonaSpain
  • UNIVERSITA DEGLI STUDI DI PERUGIA · PerugiaItaly

Links

Data: CORDIS, © European Union